SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia

Díez, Á; Cieza-Borrella, C; Suazo, V; González-Sarmiento, R; Papiol, S; Molina, V (2014) Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia. Annals of General Psychiatry, 13 (1). p. 18. ISSN 1744-859X https://doi.org/10.1186/1744-859x-13-18
SGUL Authors: Cieza-Borrella, Clara Isabel

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (238kB) | Preview

Abstract

Background Neuregulins are a family of signalling proteins that orchestrate a broad range of cellular responses. Four genes encoding Neuregulins 1–4 have been identified so far in vertebrates. Among them, Neuregulin 1 and Neuregulin 3 have been reported to contribute to an increased risk for developing schizophrenia. We hypothesized that three specific variants of these genes (rs6994992 and rs3924999 for Neuregulin 1 and rs10748842 for Neuregulin 3) that have been related to this illness may modify information processing capacity in the cortex, which would be reflected in electrophysiological parameters (P3b amplitude or gamma noise power) and/or cognitive performance. Methods We obtained DNA from 31 patients with schizophrenia and 23 healthy controls and analyzed NRG1 rs6994992, NRG1 rs3924999 and NRG3 rs10748842 promoter polymorphisms by allelic discrimination with real-time polymerase chain reaction (PCR). We compared cognitive outcome, P300 amplitude parameters and an electroencephalographic measure of noise power in the gamma band between the groups dichotomized according to genotype. Results Contrary to our hypothesis, we could not detect any significant influence of variation in Neuregulin 1/Neuregulin 3 polymorphisms on cognitive performance or electrophysiological parameters of patients with schizophrenia. Conclusions Despite our findings, we cannot discard that other genetic variants and, more likely, interactions between those variants and with genetic variation related to different pathways may still influence cerebral processing in schizophrenia.

Item Type: Article
Additional Information: © 2014 Díez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Psychiatry, 1701 Psychology
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Biomedical Education (INMEBE)
Journal or Publication Title: Annals of General Psychiatry
ISSN: 1744-859X
Language: en
Dates:
DateEvent
14 June 2014Published
29 May 2014Accepted
Publisher License: Creative Commons: Attribution 2.0
Projects:
Project IDFunderFunder ID
080017Instituto de Salud Carlos IIIhttp://dx.doi.org/10.13039/501100004587
1102203Instituto de Salud Carlos IIIhttp://dx.doi.org/10.13039/501100004587
GRS 249/A/08Gerencia Regional de Salud de Castilla y LeónUNSPECIFIED
613/A/11Gerencia Regional de Salud Castilla y LeónUNSPECIFIED
330156-CODIPSeventh Framework Programmehttp://dx.doi.org/10.13039/501100004963
EDU/1486/2008European Social Fundhttp://dx.doi.org/10.13039/501100004895
EDU/1064/2009European Social Fundhttp://dx.doi.org/10.13039/501100004895
PI 1000219FISUNSPECIFIED
URI: https://openaccess.sgul.ac.uk/id/eprint/111865
Publisher's version: https://doi.org/10.1186/1744-859x-13-18

Actions (login required)

Edit Item Edit Item